Rare diseases
Investigational molecules
Locations
Back to Greece260 clinical trials in Patras, Greece across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study of oral cladribine compared to placebo for patients with generalized myasthenia gravis
GreeceStudy of Revumenib and Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia with NPM1 Gene Mutation
GreeceTesting Treprostinil Palmitil Inhalation Powder for Improving Exercise Ability in Patients with Pulmonary Hypertension Related to Interstitial Lung Disease
GreeceA Study of MK-1084 and Drug Combination Versus Pembrolizumab and Chemotherapy for Adults with Advanced Lung Cancer with KRAS G12C Mutation
GreeceA study comparing erdafitinib delivery system to chemotherapy for patients with high-risk non-muscle-invasive bladder cancer who received BCG treatment
GreeceA Follow-up Study of Mezagitamab in Adults with Chronic Primary Immune Thrombocytopenia to Evaluate Long-term Safety and Effectiveness
GreeceA Study of BMS-986504 with Drug Combination Compared to Placebo with Drug Combination in Patients with Advanced Non-Small Cell Lung Cancer Starting First Treatment
GreeceA Study of IMVT-1402 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy to Prevent Disease Relapse
GreeceA Study of Mezagitamab Compared to Placebo for Adults with Chronic Primary Immune Thrombocytopenia
GreeceStudy of KarXT (trospium chloride and xanomeline tartrate) and KarX-EC (xanomeline tartrate) for cognitive impairment in mild to moderate Alzheimer's disease
GreeceStudy of xanomeline tartrate and trospium chloride combination for treating agitation in Alzheimer's disease patients
GreeceStudy of depemokimab to improve airway function in patients with type 2 eosinophilic asthma
GreeceThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on Sjögren's Syndrome and Systemic Sclerosis, evaluating novel therapeutic approaches with medications like sibeprenlimab and efgartigimod. These trials aim to improve treatment outcomes for patients with chronic autoimmune disorders.
Studies are exploring both long-term safety and immediate efficacy of new treatment options.
Comprehensive studies in Multiple Myeloma and advanced cancers, including trials of combination therapies and novel treatments. Research includes investigations into treatments for newly diagnosed and relapsed/refractory cases.
Focus on improving patient outcomes through targeted and combination therapies.
Groundbreaking research in Amyotrophic Lateral Sclerosis and Myasthenia Gravis, evaluating innovative treatments and therapeutic approaches for these challenging neurological conditions.
Studies are examining both disease progression and symptom management.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
